LucchinettiCFPopescuBFBunyanRF. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med2011; 365: 2188–2197.
8.
WylezinskaMCifelliAJezzardP. Thalamic neurodegeneration in relapsing–remitting multiple sclerosis. Neurology2003; 60: 1949–1954.
9.
SteenwijkMDDaamsMPouwelsPJ. What explains gray matter atrophy in long-standing multiple sclerosis?Radiology2014; 272: 832–842.
10.
StromilloMLGiorgioARossiF. Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. Neurology2013; 80: 2090–2094.
11.
FreemanLGarcia-LorenzoDBottinL. Evidence of widespread cortical neuronal damage in patients with multiple sclerosis: A surface-based study using PET with [11C]-flumazenil. Mult Scler2013; 19 Suppl. (abstract 205).
12.
MaineroCLouapreCGovindarajanST. A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging. Brain2015; 138: 932–945.
13.
BaranziniSESrinivasanRKhankhanianP. Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain2010; 133: 2603–2611.
14.
KalincikTVivekVJokubaitisV. Sex as a determinant of relapse incidence and progressive course of multiple sclerosis. Brain2013; 136: 3609–3617.
15.
SchoonheimMMPopescuVRueda LopesFC. Subcortical atrophy and cognition: Sex effects in multiple sclerosis. Neurology2012; 79: 1754–1761.
16.
DuSItohNAskarinamS. XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A2014; 111: 2806–2811.
17.
FrieseMASchattlingBFuggerL. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol2014; 10: 225–238.